Skip to main content

Share story

Products

Huawei introduces desktops using its own processor and HarmonyOS

Huawei Image: Primary
Huawei has introduced Qinyun HM650 and HM650g desktop PCs using its Kirin X90 processor and HarmonyOS Enterprise Edition, Tom's Hardware reported. The processor has 10 CPU cores supporting 20 simultaneous threads, integrated graphics and a dedicated processor for AI workloads. Huawei claims the systems' components are manufactured domestically. However, their semiconductor supply chain still depends on foreign manufacturing equipment, materials, intellectual property and design software. HarmonyOS Enterprise Edition uses Huawei's own kernel and software architecture, giving the company control over development, security updates and hardware integration. Compatibility with existing Windows applications could limit adoption by enterprise customers.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Tom's Hardware and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.